Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96M
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
16.4M
-
Shares change
-
+433K
-
Total reported value, excl. options
-
$183M
-
Value change
-
+$5.14M
-
Number of buys
-
39
-
Number of sells
-
-10
-
Price
-
$11.14
Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q2 2020
56 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q2 2020.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.4M shares
of 96M outstanding shares and own 17.13% of the company stock.
Largest 10 shareholders include 5AM Venture Management, LLC (3.67M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.57M shares), Cormorant Asset Management, LP (2.11M shares), BOXER CAPITAL, LLC (1.57M shares), Redmile Group, LLC (1.43M shares), BAKER BROS. ADVISORS LP (636K shares), MILLENNIUM MANAGEMENT LLC (632K shares), BlackRock Inc. (623K shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (464K shares), and VANGUARD GROUP INC (257K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.